TACTILE SYSTEMS TECHNOLOGY I (TCMD)
US87357P1003 - Common Stock
TCMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 193 industry peers in the Health Care Equipment & Supplies industry. TCMD gets an excellent profitability rating and is at the same time showing great financial health properties. TCMD has a correct valuation and a medium growth rate. These ratings could make TCMD a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year TCMD was profitable.
In the past year TCMD had a positive cash flow from operations.
In multiple years TCMD reported negative net income over the last 5 years.
Each year in the past 5 years TCMD had a positive operating cash flow.
1.2 Ratios
TCMD has a better Return On Assets (10.13%) than 93.78% of its industry peers.
Looking at the Return On Equity, with a value of 14.72%, TCMD belongs to the top of the industry, outperforming 90.67% of the companies in the same industry.
The Return On Invested Capital of TCMD (5.93%) is better than 81.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.13% | ||
| ROE | 14.72% | ||
| ROIC | 5.93% |
ROA(3y)-0.57%
ROA(5y)1.04%
ROE(3y)-3.07%
ROE(5y)0.01%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TCMD's Profit Margin of 10.39% is amongst the best of the industry. TCMD outperforms 86.01% of its industry peers.
In the last couple of years the Profit Margin of TCMD has grown nicely.
With a decent Operating Margin value of 6.57%, TCMD is doing good in the industry, outperforming 72.02% of the companies in the same industry.
TCMD's Operating Margin has improved in the last couple of years.
TCMD has a Gross Margin (49.94%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TCMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.57% | ||
| PM (TTM) | 10.39% | ||
| GM | 49.94% |
OM growth 3YN/A
OM growth 5Y25.8%
PM growth 3YN/A
PM growth 5Y17.75%
GM growth 3Y1.41%
GM growth 5Y0.89%
2. Health
2.1 Basic Checks
TCMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TCMD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TCMD has more shares outstanding
TCMD has a better debt/assets ratio than last year.
2.2 Solvency
TCMD has an Altman-Z score of 3.94. This indicates that TCMD is financially healthy and has little risk of bankruptcy at the moment.
TCMD's Altman-Z score of 3.94 is fine compared to the rest of the industry. TCMD outperforms 73.06% of its industry peers.
The Debt to FCF ratio of TCMD is 0.87, which is an excellent value as it means it would take TCMD, only 0.87 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of TCMD (0.87) is better than 91.71% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that TCMD is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.14, TCMD perfoms like the industry average, outperforming 55.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 0.87 | ||
| Altman-Z | 3.94 |
ROIC/WACC0.59
WACC9.97%
2.3 Liquidity
TCMD has a Current Ratio of 3.54. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
TCMD has a Current ratio (3.54) which is comparable to the rest of the industry.
TCMD has a Quick Ratio of 2.99. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
TCMD's Quick ratio of 2.99 is in line compared to the rest of the industry. TCMD outperforms 59.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.54 | ||
| Quick Ratio | 2.99 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 310.53% over the past year.
TCMD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.62% yearly.
TCMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.20%.
TCMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.80% yearly.
EPS 1Y (TTM)310.53%
EPS 3Y121.78%
EPS 5Y20.62%
EPS growth Q2Q52.17%
Revenue 1Y (TTM)11.2%
Revenue growth 3Y13.62%
Revenue growth 5Y13.8%
Revenue growth Q2Q5.08%
3.2 Future
TCMD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.12% yearly.
The Revenue is expected to grow by 11.16% on average over the next years. This is quite good.
EPS Next Y-51.76%
EPS Next 2Y-11.09%
EPS Next 3Y3.12%
EPS Next 5YN/A
Revenue Next Year10.1%
Revenue Next 2Y11.72%
Revenue Next 3Y11.16%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
TCMD is valuated reasonably with a Price/Earnings ratio of 11.41.
Based on the Price/Earnings ratio, TCMD is valued cheaper than 96.37% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.91. TCMD is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 23.65, the valuation of TCMD can be described as rather expensive.
81.87% of the companies in the same industry are more expensive than TCMD, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.51. TCMD is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.41 | ||
| Fwd PE | 23.65 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TCMD is valued cheaper than 92.75% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TCMD is valued cheaper than 97.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.75 | ||
| EV/EBITDA | 10.72 |
4.3 Compensation for Growth
TCMD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.55
EPS Next 2Y-11.09%
EPS Next 3Y3.12%
5. Dividend
5.1 Amount
No dividends for TCMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TACTILE SYSTEMS TECHNOLOGY I
NASDAQ:TCMD (5/15/2024, 3:30:00 PM)
After market: 13.69 0 (0%)13.69
+0.06 (+0.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap325.27M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.41 | ||
| Fwd PE | 23.65 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.13% | ||
| ROE | 14.72% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 6.57% | ||
| PM (TTM) | 10.39% | ||
| GM | 49.94% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.54 | ||
| Quick Ratio | 2.99 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)310.53%
EPS 3Y121.78%
EPS 5Y
EPS growth Q2Q
EPS Next Y-51.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.2%
Revenue growth 3Y13.62%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y